butyric acid has been researched along with Melanoma in 16 studies
Butyric Acid: A four carbon acid, CH3CH2CH2COOH, with an unpleasant odor that occurs in butter and animal fat as the glycerol ester.
butyrate : A short-chain fatty acid anion that is the conjugate base of butyric acid, obtained by deprotonation of the carboxy group.
butyric acid : A straight-chain saturated fatty acid that is butane in which one of the terminal methyl groups has been oxidised to a carboxy group.
Melanoma: A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment of B16-F10 melanoma cells with dimethylsulfoxide (DMSO) or butyric acid (BA) inhibits cell growth and delays tumor appearance in syngeneic mice." | 7.67 | Growth inhibition of murine melanoma by butyric acid and dimethylsulfoxide. ( Aloni, D; Beery, E; Malik, H; Nordenberg, J; Novogrodsky, A; Stenzel, KH; Wasserman, L, 1986) |
| "Sodium butyrate (butyrate), 5-azacytidine (5Aza-C), dimethyl sulfoxide (DMSO), and dimethyl formamide (DMF) were applied to a human melanoma cell line for the purpose of inducing pigmentation and terminal differentiation." | 3.68 | In vitro phenotypic alteration of human melanoma cells induced by differentiating agents: heterogeneous effects on cellular growth and morphology, enzymatic activity, and antigenic expression. ( Parsons, PG; Takahashi, H, 1990) |
| "Treatment of B16-F10 melanoma cells with dimethylsulfoxide (DMSO) or butyric acid (BA) inhibits cell growth and delays tumor appearance in syngeneic mice." | 3.67 | Growth inhibition of murine melanoma by butyric acid and dimethylsulfoxide. ( Aloni, D; Beery, E; Malik, H; Nordenberg, J; Novogrodsky, A; Stenzel, KH; Wasserman, L, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (37.50) | 18.7374 |
| 1990's | 6 (37.50) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Shashni, B | 1 |
| Nagasaki, Y | 1 |
| Lakhter, AJ | 1 |
| Hamilton, J | 1 |
| Konger, RL | 1 |
| Brustovetsky, N | 1 |
| Broxmeyer, HE | 1 |
| Naidu, SR | 1 |
| Bandyopadhyay, D | 1 |
| Mishra, A | 1 |
| Medrano, EE | 1 |
| Ichikawa, N | 1 |
| Miyashita, T | 1 |
| Nishimune, Y | 1 |
| Matsushiro, A | 1 |
| Linge, C | 1 |
| Gewert, D | 1 |
| Rossmann, C | 1 |
| Bishop, JA | 1 |
| Crowe, JS | 1 |
| Wu, QH | 1 |
| Trymbulak, W | 1 |
| Tatake, RJ | 1 |
| Forman, SJ | 1 |
| Zeff, RA | 1 |
| Shanley, JD | 1 |
| Zhai, Y | 1 |
| Yang, JC | 1 |
| Kawakami, Y | 1 |
| Spiess, P | 1 |
| Wadsworth, SC | 1 |
| Cardoza, LM | 1 |
| Couture, LA | 1 |
| Smith, AE | 1 |
| Rosenberg, SA | 1 |
| Edward, M | 1 |
| Godden, JL | 1 |
| Alexander, CL | 1 |
| MacKie, RM | 1 |
| Salomone, B | 1 |
| Ponti, R | 1 |
| Gasco, MR | 1 |
| Ugazio, E | 1 |
| Quaglino, P | 1 |
| Osella-Abate, S | 1 |
| Bernengo, MG | 1 |
| Takahashi, H | 2 |
| Parsons, PG | 2 |
| Sturm, RA | 1 |
| Bisshop, F | 1 |
| Nordenberg, J | 3 |
| Wasserman, L | 2 |
| Peled, A | 2 |
| Malik, Z | 1 |
| Stenzel, KH | 2 |
| Novogrodsky, A | 3 |
| Niles, RM | 1 |
| Beery, E | 1 |
| Aloni, D | 1 |
| Malik, H | 1 |
| Adler, A | 1 |
| Nozawa, S | 1 |
| Tsai, DZ | 1 |
| Sakayori, M | 1 |
| Iizuka, R | 1 |
| Nishimura, R | 1 |
| Mochizuki, M | 1 |
1 review available for butyric acid and Melanoma
| Article | Year |
|---|---|
Chemical induction of tumor cell differentiation.
Topics: Animals; Butyrates; Butyric Acid; Cell Division; Cell Line; Cell Transformation, Neoplastic; Choleca | 1985 |
15 other studies available for butyric acid and Melanoma
| Article | Year |
|---|---|
Short-chain fatty acid-releasing nano-prodrugs for attenuating growth and metastasis of melanoma.
Topics: Animals; Butyric Acid; Fatty Acids, Volatile; Melanoma; Mice | 2023 |
Glucose-independent Acetate Metabolism Promotes Melanoma Cell Survival and Tumor Growth.
Topics: Acetates; Acetyl-CoA Carboxylase; Adenosine Triphosphate; Animals; Butyric Acid; Cell Line, Tumor; F | 2016 |
Overexpression of histone deacetylase 1 confers resistance to sodium butyrate-mediated apoptosis in melanoma cells through a p53-mediated pathway.
Topics: Apoptosis; bcl-2-Associated X Protein; Butyric Acid; Cell Line, Tumor; Histone Deacetylase 1; Histon | 2004 |
Production, purification and characterization of the plasminogen activator in teratocarcinoma stem cells induced with sodium butyrate.
Topics: Animals; Butyrates; Butyric Acid; Cell Line; Cell Transformation, Neoplastic; Electrophoresis, Polya | 1984 |
Interferon system defects in human malignant melanoma.
Topics: Base Sequence; Butyrates; Butyric Acid; Genes, Tumor Suppressor; Humans; Interferon-alpha; Interfero | 1995 |
Replication of human cytomegalovirus in cells deficient in beta 2-microglobulin gene expression.
Topics: Animals; beta 2-Microglobulin; Butyrates; Butyric Acid; Cell Line; Cells, Cultured; Cytomegalovirus; | 1994 |
Antigen-specific tumor vaccines. Development and characterization of recombinant adenoviruses encoding MART1 or gp100 for cancer therapy.
Topics: Adenoviridae; Adenovirus E3 Proteins; Animals; Antigens, Neoplasm; Butyrates; Butyric Acid; Cell Lin | 1996 |
Effect of retinoic acid on melanoma cell-derived factor stimulation of fibroblast glycosaminoglycan synthesis.
Topics: Acetamides; Adult; Antineoplastic Agents; Butyrates; Butyric Acid; Cell Count; Cell Differentiation; | 1997 |
In vitro effects of cholesteryl butyrate solid lipid nanospheres as a butyric acid pro-drug on melanoma cells: evaluation of antiproliferative activity and apoptosis induction.
Topics: Annexin A5; Apoptosis; Butyric Acid; Cell Division; Cholesterol Esters; Dose-Response Relationship, | 2000 |
In vitro phenotypic alteration of human melanoma cells induced by differentiating agents: heterogeneous effects on cellular growth and morphology, enzymatic activity, and antigenic expression.
Topics: Antigens, Neoplasm; Azacitidine; Butyrates; Butyric Acid; Cell Cycle; Cell Differentiation; Cell Div | 1990 |
A melanoma octamer binding protein is responsive to differentiating agents.
Topics: Butyrates; Butyric Acid; Cell Differentiation; Cell Line, Transformed; Dimethyl Sulfoxide; Dithiothr | 1991 |
Biochemical and ultrastructural alterations accompany the anti-proliferative effect of butyrate on melanoma cells.
Topics: Animals; Butyrates; Butyric Acid; Cell Line; Clone Cells; Endoplasmic Reticulum; gamma-Glutamyltrans | 1987 |
Growth inhibition of murine melanoma by butyric acid and dimethylsulfoxide.
Topics: Animals; Butyrates; Butyric Acid; Cell Division; Cell Line; Cell Survival; Dimethyl Sulfoxide; Melan | 1986 |
[Inhibition of growth of human melanoma cells and enhancement of alkaline phosphatase activity by butyric acid].
Topics: Alkaline Phosphatase; Butyrates; Butyric Acid; Cell Differentiation; Cell Line; GPI-Linked Proteins; | 1986 |
HCG production of non-trophoblastic cancer cell lines and its modulation by sodium butyrate.
Topics: Adenocarcinoma; Butyrates; Butyric Acid; Carcinoma, Squamous Cell; Cell Line; Chorionic Gonadotropin | 1985 |